Skip to main content
. Author manuscript; available in PMC: 2013 Oct 23.
Published in final edited form as: Arch Pathol Lab Med. 2012 Jun;136(6):610–617. doi: 10.5858/arpa.2011-0371-OA

Table 1.

Consensus Panel Recommendations on HER2/neu Immunohistochemistry Scoring for Gastroesophageal Adenocarcinoma Biopsy and Resection Specimensa

Reactivity Characteristics Score/Classification
Resection specimens
 No reactivity (at ×40 magnification) 0/negative
 Membranous reactivity in <10% of cells
 Faint/barely perceptible partial membranous reactivity in >10% of tumor cells (at ×40 magnification) 1+/negative
 Weak/moderate complete OR basolateral/lateral membranous reactivity in >10% of tumor cells (at ×10–×20 magnification) 2+/equivocal
 Moderate/strong complete OR basolateral/lateral membranous reactivity in >10% of tumor cells 3+/positive
 Unequivocal membranous staining at low magnification (×2.5/×5)
Biopsy specimens
 Any single cluster of tumor cells (≥5 cells) demonstrating IHC 3+ staining characteristics 3+/positive

Abbreviation: HER2/neu, human epidermal growth factor receptor 2; IHC, immunohistochemistry.

a

Adapted from Hoffman et al13 and Rüschoff et al.25 Reprinted with permission.